Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences Files Shelf Registration for Sale of Securities

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences announced after the close of the market on Tuesday that it has filed a universal shelf registration for the sale from time to time of up to $150 million in securities.

In the form S-3 filed with the US Securities and Exchange Commission, the company said that proceeds from the sale will be used for general corporate purposes and working capital, which includes funding efforts to obtain clearance from the US Food and Drug Administration of its stool-based DNA colorectal cancer screening product.

Exact Sciences said in a statement that the registration statement has not yet become effective and added that it has no immediate plans to offer securities under the shelf registration. Terms of any offering will be determined at the time of the offering.

In April, the Madison, Wis.-based molecular diagnostics firm completed a public offering of 4.2 million shares of its common stock at $4.50 to raise about $17.6 million in net proceeds.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.